leisure time -WSS

leisure time

author：explore 2025-09-29 01:45:34 - browse：31292

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And will there ever be an Apple of pharma?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. In the wake of a massively important clinical trial of Novo Nordisk’s obesity drug Wegovy, our colleague Elaine Chen joins us to explain what we know and don’t know about data that could change the practice of medicine. Then, Mizuho Securities biotech strategist Jared Holz calls in to discuss whether explosive popularity of obesity treatments could help create the first trillion-dollar drug company.

For more on what we cover, here’s the news on the Wegovy study; here’s more on its implications; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Anxious about a speech? A startup wants you to pop a minty cardiac drug

WSS

New Medicare drug pricing powers could soon be upended in court

It's time to retire 'poor historian' from clinicians' vocabularies

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

New Medicare drug pricing powers could soon be upended in court

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

leisure time

leisure time

knowledge

The high cost of giving birth even with insurance

Caregivers of transplant patients call for more support, training

Peter Hotez and the public health issue of online harassment

New Medicare drug pricing powers could soon be upended in court

Bright Health sells Medicare Advantage business to Molina

When prostate cancer spreads, where it goes matters

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Case highlights the risks of experimental stem cell therapy

Malaria cases in Florida and Texas: Here’s what you need to know

Fauci’s Covid grilling leads GOP to weigh foreign research rules

hotspot

Readers respond to H5N1 and livestock movements, and more

Designating disabled people as health disparity population is crucial

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

NVIDIA and Google execs on the future of AI and drug discovery

Criminal prosecution for violating HIPAA: an emerging threat

As JPM 2024 winds down, some health tech firms project optimism

hotspot

hotspot

hotspot

hotspot